<table id="T1" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.<sup>¶</sup>
</caption>
<thead>
<tr>
<th align="left" colspan="2" valign="bottom">Population Characteristics</th>
<th align="center" valign="bottom">Total body clearance*<br/>mean (range)<sup>††</sup>
<br/>(mL/kg/min)</th>
<th align="center" valign="bottom">Half-life mean (range)<sup>††</sup>
<br/>(hr)</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4">
<sup>¶</sup>For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</td>
</tr>
<tr>
<td colspan="4">*Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics.</td>
</tr>
<tr>
<td colspan="4">
<sup>††</sup>Reported range or estimated range (mean ±2 SD) where actual range not reported.</td>
</tr>
<tr>
<td colspan="4">†NR=not reported or not reported in a comparable format.</td>
</tr>
<tr>
<td colspan="4">**Median</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" colspan="4">
<content stylecode="bold">
<content stylecode="underline">Age</content>
</content>
</td>
</tr>
<tr>
<td align="left" colspan="4">Premature neonates</td>
</tr>
<tr>
<td> </td>
<td align="left">postnatal age 3-15 days</td>
<td align="center">0.29 (0.09-0.49)</td>
<td align="center">30 (17-43)</td>
</tr>
<tr>
<td> </td>
<td align="left">postnatal age 25-57 days</td>
<td align="center">0.64 (0.04-1.2)</td>
<td align="center">20 (9.4-30.6)</td>
</tr>
<tr>
<td align="left" colspan="4">Term infants</td>
</tr>
<tr>
<td> </td>
<td align="left">postnatal age 1-2 days</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">25.7 (25-26.5)</td>
</tr>
<tr>
<td> </td>
<td align="left">postnatal age 3-30 weeks</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">11 (6-29)</td>
</tr>
<tr>
<td align="left" colspan="4">Children</td>
</tr>
<tr>
<td> </td>
<td align="left">1-4 years</td>
<td align="center">1.7 (0.5-2.9)</td>
<td align="center">3.4 (1.2-5.6)</td>
</tr>
<tr>
<td> </td>
<td align="left">4-12 years</td>
<td align="center">1.6 (0.8-2.4)</td>
<td align="center">NR<sup>†</sup>
</td>
</tr>
<tr>
<td> </td>
<td align="left">13-15 years</td>
<td align="center">0.9 (0.48-1.3)</td>
<td align="center">NR<sup>†</sup>
</td>
</tr>
<tr>
<td> </td>
<td align="left">6-17 years</td>
<td align="center">1.4 (0.2-2.6)</td>
<td align="center">3.7 (1.5-5.9)</td>
</tr>
<tr>
<td align="left" colspan="4">Adults (16-60 years)</td>
</tr>
<tr>
<td> </td>
<td align="left">otherwise healthy</td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr>
<td> </td>
<td align="left">non-smoking asthmatics</td>
<td align="center">0.65 (0.27-1.03)</td>
<td align="center">8.7 (6.1-12.8)</td>
</tr>
<tr>
<td align="left" colspan="4">Elderly (&gt;60 years)</td>
</tr>
<tr>
<td> </td>
<td align="left">non-smokers with normal<br/>cardiac,<br/>liver, and renal function</td>
<td align="center" valign="bottom">0.41 (0.21-0.61)</td>
<td align="center" valign="bottom">9.8 (1.6-18)</td>
</tr>
<tr>
<td align="left" colspan="4">
<content stylecode="bold">
<content stylecode="underline">Concurrent illness or altered physiological state</content>
</content>
</td>
</tr>
<tr>
<td align="left" colspan="2">Acute pulmonary edema</td>
<td align="center">0.33** (0.07-2.45)</td>
<td align="center">19** (3.1-82)</td>
</tr>
<tr>
<td align="left" colspan="4">COPD-&gt;60 years, stable</td>
</tr>
<tr>
<td> </td>
<td align="left">non-smoker &gt;1 year</td>
<td align="center">0.54 (0.44-0.64)</td>
<td align="center">11 (9.4-12.6)</td>
</tr>
<tr>
<td align="left" colspan="2">COPD with cor pulmonale</td>
<td align="center">0.48 (0.08-0.88)</td>
<td align="center">NR<sup>†</sup>
</td>
</tr>
<tr>
<td align="left" colspan="2">Cystic fibrosis (14-28 years)</td>
<td align="center">1.25 (0.31-2.2)</td>
<td align="center">6.0 (1.8-10.2)</td>
</tr>
<tr>
<td align="left" colspan="4">Fever associated with</td>
</tr>
<tr>
<td> </td>
<td align="left">acute viral respiratory illness</td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr>
<td> </td>
<td align="left">(children 9-15 years)</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">7.0 (1.0-13)</td>
</tr>
<tr>
<td align="left" colspan="4">Liver disease</td>
</tr>
<tr>
<td> </td>
<td align="left">cirrhosis</td>
<td align="center">0.31** (0.1-0.7)</td>
<td align="center">32** (10-56)</td>
</tr>
<tr>
<td> </td>
<td align="left">acute hepatitis</td>
<td align="center">0.35 (0.25-0.45)</td>
<td align="center">19.2 (16.6-21.8)</td>
</tr>
<tr>
<td> </td>
<td align="left">cholestasis</td>
<td align="center">0.65 (0.25-1.45)</td>
<td align="center">14.4 (5.7-31.8)</td>
</tr>
<tr>
<td align="left" colspan="4">Pregnancy</td>
</tr>
<tr>
<td> </td>
<td align="left">1st trimester</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">8.5 (3.1-13.9)</td>
</tr>
<tr>
<td> </td>
<td align="left">2nd trimester</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">8.8 (3.8-13.8)</td>
</tr>
<tr>
<td> </td>
<td align="left">3rd trimester</td>
<td align="center">NR<sup>†</sup>
</td>
<td align="center">13.0 (8.4-17.6)</td>
</tr>
<tr>
<td align="left" colspan="2">Sepsis with multi-organ failure</td>
<td align="center">0.47 (0.19-1.9)</td>
<td align="center">18.8 (6.3-24.1)</td>
</tr>
<tr>
<td align="left" colspan="4">Thyroid disease</td>
</tr>
<tr>
<td> </td>
<td align="left">hypothyroid</td>
<td align="center">0.38 (0.13-0.57)</td>
<td align="center">11.6 (8.2-25)</td>
</tr>
<tr>
<td> </td>
<td align="left">hyperthyroid</td>
<td align="center">0.8 (0.68-0.97)</td>
<td align="center">4.5 (3.7-5.6)</td>
</tr>
</tbody>
</table>